Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab(legacy) | 221 |
| Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab(legacy) | 68 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab | 1 | 5 | 0 | 4 | 1 | 1 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 66 |
| China | 35 |
| France | 18 |
| Australia | 8 |
| Netherlands | 8 |
| Vietnam | 5 |
| Germany | 1 |
| Finland | 1 |
| Ireland | 1 |
| Russia | 1 |
Top City Views
| Views | |
|---|---|
| Beijing | 24 |
| Ashburn | 23 |
| Rotterdam | 8 |
| Kaleen | 7 |
| Fairfield | 5 |
| Hanoi | 5 |
| Zhengzhou | 4 |
| Ann Arbor | 3 |
| Cambridge | 3 |
| Dearborn | 3 |